BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35292877)

  • 21. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia.
    Weel IC; Baergen RN; Romão-Veiga M; Borges VT; Ribeiro VR; Witkin SS; Bannwart-Castro C; Peraçoli JC; De Oliveira L; Peraçoli MT
    PLoS One; 2016; 11(6):e0157584. PubMed ID: 27315098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes.
    Leaños-Miranda A; Méndez-Aguilar F; Ramírez-Valenzuela KL; Serrano-Rodríguez M; Berumen-Lechuga G; Molina-Pérez CJ; Isordia-Salas I; Campos-Galicia I
    Medicine (Baltimore); 2017 Jan; 96(4):e6005. PubMed ID: 28121958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
    Gu Y; Lewis DF; Wang Y
    J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
    Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
    Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
    Stepan H; Hund M; Andraczek T
    Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients.
    Zhu X; Chen L; Li R
    Clin Exp Hypertens; 2020 Oct; 42(7):601-607. PubMed ID: 32338084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma.
    Chaiworapongsa T; Romero R; Gotsch F; Kusanovic JP; Mittal P; Kim SK; Erez O; Vaisbuch E; Mazaki-Tovi S; Kim CJ; Dong Z; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Feb; 23(2):167-78. PubMed ID: 20213923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
    Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
    Ren Z; Cui N; Zhu M; Khalil RA
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenic profiling in HELLP syndrome cases with or without hypertension and proteinuria.
    Trottmann F; Baumann M; Amylidi-Mohr S; Surbek D; Risch L; Mosimann B; Raio L
    Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():93-96. PubMed ID: 31678761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Placental Growth Factor Levels in Maternal Serum at Early Pregnancy between Normotensive Pregnant Women and Patients with Hypertensive Disorders in Pregnancy.
    Sultana MT; Begum F; Akhter N; Parveen T; Kakan FB; Sattar MS
    Mymensingh Med J; 2020 Jul; 29(3):609-615. PubMed ID: 32844801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Copeptin and mid-regional pro-atrial natriuretic peptide in women with suspected or confirmed pre-eclampsia: comparison with sFlt-1/PlGF ratio.
    Neuman RI; van der Meer MMA; Saleh L; van den Berg SAA; van den Meiracker AH; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2020 Dec; 56(6):872-878. PubMed ID: 31975510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM).
    Walentowicz-Sadlecka M; Domaracki P; Sadlecki P; Siodmiak J; Grabiec M; Walentowicz P; Moliz MTA; Odrowaz-Sypniewska G
    Dis Markers; 2019; 2019():5870239. PubMed ID: 31481983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-1 as a novel risk factor for both gestational hypertension and preeclampsia, specifially its expression at a low level in the second trimester and a high level after onset.
    Hirashima C; Ohkuchi A; Nagayama S; Suzuki H; Takahashi K; Ogoyama M; Takahashi H; Shirasuna K; Matsubara S
    Hypertens Res; 2018 Jan; 41(1):45-52. PubMed ID: 28978981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating cardiovascular biomarkers during and after preeclampsia: Crosstalk with placental function?
    Jacobsen DP; Røysland R; Strand H; Moe K; Sugulle M; Omland T; Staff AC
    Pregnancy Hypertens; 2022 Dec; 30():103-109. PubMed ID: 36148698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
    Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
    Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia.
    Rădulescu C; Bacârea A; Huțanu A; Gabor R; Dobreanu M
    Mediators Inflamm; 2016; 2016():3027363. PubMed ID: 27799724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia.
    Matin M; Mörgelin M; Stetefeld J; Schermer B; Brinkkoetter PT; Benzing T; Koch M; Hagmann H
    Hypertension; 2020 Oct; 76(4):1176-1184. PubMed ID: 32623922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.